- Presentations
- 2
- Markets
- 1
Abilify Asimtufii is a brand of Aripiprazole marketed by Otsuka America Pharmaceutical, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Aripiprazole
- Brand owner
- Otsuka America Pharmaceutical
- Registered in
- United States
- Strengths and forms
- 720 mg/2.4 mL extended-release injectable suspension, 960 mg/3.2 mL extended-release injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Abilify Asimtufii 720 mg/2.4 mL extended-release injectable suspensionIntramuscular | Otsuka America Pharmaceutical | US FDA | Available on request |
| Abilify Asimtufii 960 mg/3.2 mL extended-release injectable suspensionIntramuscular | Otsuka America Pharmaceutical | US FDA | Available on request |
Equivalent brands
Other brands of Aripiprazole.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Abilify Asimtufii
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.